A Phase 2b, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study of HTX-019 as Treatment for Postoperative Nausea and Vomiting Following Failed Antiemetic Prophylaxis

Administered By

Awarded By

Contributors

Start/End

  • July 8, 2021 - June 30, 2024